Pathogenic Mutations in the C2A Domain of Dysferlin form Amyloid that Activates the Inflammasome
暂无分享,去创建一个
R. Sutton | P. Bhattacharjee | G. Cornwall | M. J. Dominguez | Faraz M. Harsini | K. Fuson | Peter A. Keyel | Adam Snow | Justin Williams | Isaac L. Scott | Roshan Thapa | Pushpak Bhattacharjee
[1] Roshan J. Thapa,et al. Patch repair protects cells from the small pore-forming toxin aerolysin , 2022, bioRxiv.
[2] S. Brichard,et al. Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy , 2022, Frontiers in Immunology.
[3] Samrat Moitra,et al. Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins using Leishmania major. , 2022, Journal of visualized experiments : JoVE.
[4] B. Everts,et al. The NLRP3 inflammasome contributes to inflammation‐induced morphological and metabolic alterations in skeletal muscle , 2022, Journal of cachexia, sarcopenia and muscle.
[5] J. Kardos,et al. BeStSel: webserver for secondary structure and fold prediction for protein CD spectroscopy , 2022, Nucleic Acids Res..
[6] Robyn Roth,et al. Membrane repair triggered by cholesterol-dependent cytolysins is activated by mixed lineage kinases and MEK , 2022, Science advances.
[7] Karra A. Jones,et al. The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies , 2022, Acta neuropathologica communications.
[8] R. Sutton,et al. Redefining the architecture of ferlin proteins: Insights into multi-domain protein structure and function , 2022, bioRxiv.
[9] L. Guarente,et al. 4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations , 2021, iScience.
[10] Ivet Bahar,et al. ProDy 2.0: increased scale and scope after 10 years of protein dynamics modelling with Python , 2021, Bioinform..
[11] P. Mercier,et al. Calcium binds and rigidifies the dysferlin C2A domain in a tightly coupled manner. , 2021, The Biochemical journal.
[12] R. W. Janes,et al. PDBMD2CD: providing predicted protein circular dichroism spectra from multiple molecular dynamics-generated protein structures , 2020, Nucleic Acids Res..
[13] J. R. Long,et al. Enhanced purification coupled with biophysical analyses shows cross-β structure as a core building block for Streptococcus mutans functional amyloids , 2020, Scientific Reports.
[14] Benjamin J. Wylie,et al. The Functional Mammalian CRES (Cystatin-Related Epididymal Spermatogenic) Amyloid is Antiparallel β-Sheet Rich and Forms a Metastable Oligomer During Assembly , 2019, Scientific Reports.
[15] Peter A Keyel,et al. Multiple Parameters Beyond Lipid Binding Affinity Drive Cytotoxicity of Cholesterol-Dependent Cytolysins , 2018, Toxins.
[16] R. Salter,et al. Dnase1L3 Regulates Inflammasome-Dependent Cytokine Secretion , 2017, Front. Immunol..
[17] D. Liebetanz,et al. Dysferlin mediates membrane tubulation and links T-tubule biogenesis to muscular dystrophy , 2017, Journal of Cell Science.
[18] P. Bhattacharjee,et al. Intrinsic repair protects cells from pore-forming toxins by microvesicle shedding , 2017, Cell Death and Differentiation.
[19] Alexander D. MacKerell,et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field , 2015, Journal of chemical theory and computation.
[20] P. Mcneil,et al. Membrane Repair: Mechanisms and Pathophysiology. , 2015, Physiological reviews.
[21] Peter A Keyel,et al. How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. , 2014, Cytokine.
[22] A. Meyer,et al. Alternate splicing of dysferlin C2A confers Ca²⁺-dependent and Ca²⁺-independent binding for membrane repair. , 2014, Structure.
[23] G. Núñez,et al. 3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome* , 2013, The Journal of Biological Chemistry.
[24] Simon C Watkins,et al. Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation , 2013, The Journal of Immunology.
[25] Robyn Roth,et al. Reduction of Streptolysin O (SLO) Pore-Forming Activity Enhances Inflammasome Activation , 2013, Toxins.
[26] Stavros J. Hamodrakas,et al. A Consensus Method for the Prediction of ‘Aggregation-Prone’ Peptides in Globular Proteins , 2013, PloS one.
[27] K. Kameyama,et al. The C2A domain in dysferlin is important for association with MG53 (TRIM72) , 2012, PLoS currents.
[28] Peter A Keyel,et al. Coordinate Stimulation of Macrophages by Microparticles and TLR Ligands Induces Foam Cell Formation , 2012, The Journal of Immunology.
[29] Simon C Watkins,et al. Visualization of bacterial toxin induced responses using live cell fluorescence microscopy. , 2012, Journal of visualized experiments : JoVE.
[30] A. Aderem,et al. Caspase‐1‐induced pyroptotic cell death , 2011, Immunological reviews.
[31] Peter A Keyel,et al. Macrophage responses to bacterial toxins: a balance between activation and suppression , 2011, Immunologic research.
[32] J. Gastier-Foster,et al. Novel diagnostic features of dysferlinopathies , 2010, Muscle & nerve.
[33] E. Hoffman,et al. Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. , 2010, The American journal of pathology.
[34] Bartek Wilczynski,et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics , 2009, Bioinform..
[35] C. Béroud,et al. Analysis of the DYSF mutational spectrum in a large cohort of patients , 2009, Human mutation.
[36] B. Cookson,et al. Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.
[37] Taehoon Kim,et al. CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..
[38] K. Moore,et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.
[39] Nancy N. Byl,et al. What can we learn from animal models , 2008 .
[40] K. Bushby,et al. Dysferlin‐deficient muscular dystrophy features amyloidosis , 2008, Annals of neurology.
[41] Wim Jiskoot,et al. Extrinsic Fluorescent Dyes as Tools for Protein Characterization , 2008, Pharmaceutical Research.
[42] H. Schulz,et al. Dysfunction of dysferlin-deficient hearts , 2007, Journal of Molecular Medicine.
[43] F. Martinon,et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.
[44] K. Campbell,et al. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. , 2007, The Journal of clinical investigation.
[45] Richard T. Lee,et al. Torn apart: membrane rupture in muscular dystrophies and associated cardiomyopathies. , 2007, The Journal of clinical investigation.
[46] Robert H. Brown,et al. Dysferlin in Membrane Trafficking and Patch Repair , 2007, Traffic.
[47] J. T. Dunnen,et al. AHNAK a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] C. Paradas,et al. Dysferlin expression in monocytes: A source of mRNA for mutation analysis , 2007, Neuromuscular Disorders.
[49] F. Martinon,et al. Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.
[50] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[51] J. Meldolesi,et al. Enlargeosome, an exocytic vesicle resistant to nonionic detergents, undergoes endocytosis via a nonacidic route. , 2004, Molecular biology of the cell.
[52] K. Campbell,et al. Dysferlin and the plasma membrane repair in muscular dystrophy. , 2004, Trends in cell biology.
[53] P. Mcneil,et al. Plasma membrane disruption: repair, prevention, adaptation. , 2003, Annual review of cell and developmental biology.
[54] Chien-Chang Chen,et al. Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.
[55] J. Dubochet,et al. Conversion of a transmembrane to a water-soluble protein complex by a single point mutation , 2002, Nature Structural Biology.
[56] D. Davis,et al. Calcium-sensitive Phospholipid Binding Properties of Normal and Mutant Ferlin C2 Domains* , 2002, The Journal of Biological Chemistry.
[57] E. Caler,et al. Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes , 2001, Cell.
[58] V. Sukhorukov,et al. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy , 2000, Neurology.
[59] T. Südhof,et al. Solution structures of the Ca2+-free and Ca2+-bound C2A domain of synaptotagmin I: does Ca2+ induce a conformational change? , 1998, Biochemistry.
[60] H. M. Fishman,et al. Endocytotic Formation of Vesicles and Other Membranous Structures Induced by Ca2+ and Axolemmal Injury , 1998, The Journal of Neuroscience.
[61] N. A. Rodionova,et al. Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe , 1991, Biopolymers.
[62] M. Hosokawa,et al. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.
[63] L. Serpell,et al. X-ray fiber diffraction of amyloid fibrils. , 1999, Methods in enzymology.
[64] P. Mcneil,et al. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. , 1992, The American journal of pathology.